The store will not work correctly when cookies are disabled.
ID: ALA214990
Max Phase: Preclinical
Molecular Formula: C11H11NOS
Molecular Weight: 205.28
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CSCc1ccc(-c2cccnc2)o1
Standard InChI: InChI=1S/C11H11NOS/c1-14-8-10-4-5-11(13-10)9-3-2-6-12-7-9/h2-7H,8H2,1H3
Standard InChI Key: QSLAHFFHHYZNQL-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 205.28 | Molecular Weight (Monoisotopic): 205.0561 | AlogP: 3.20 | #Rotatable Bonds: 3 |
Polar Surface Area: 26.03 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.17 | CX LogP: 2.10 | CX LogD: 2.10 |
Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.77 | Np Likeness Score: -1.54 |
References
1. Yano JK, Denton TT, Cerny MA, Zhang X, Johnson EF, Cashman JR.. (2006) Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization., 49 (24): [PMID:17125252] [10.1021/jm060519r] |
2. (2013) Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer, |